Anteris Technologies Global Corp. (AVR) Research

Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.

Market snapshot

Symbol
AVR
Price
$9.78
Day change
+2.95%
Market cap
$359.8M
P/E ratio
-2.42x
52-week range
2.85-10.14
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$16.50

Recent news

  • Pennon returns to profit after water bill hikes

    Pennon Group PLC (LSE:PNN, OTC:PEGRY) returned to the black in its latest financial as higher regulatory allowances and increased water consumption boosted...

  • Anteris adds Susan Knight, Stephen Denaro to board as company advances heart valve strategy

    Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has strengthened its board with the appointments of experienced healthcare and finance executive Susan...

  • Anteris advances PARADIGM trial as Q1 cash burn reflects commercialisation push

    Anteris Technologies Pty Ltd (ASX:AVR, NASDAQ:AVR) has reported strong operational progress for the March 2026 quarter as the company advanced recruitment...

Peer companies

  • Anika Therapeutics, Inc. (ANIK)
  • Accuray Incorporated (ARAY)
  • Atlantic International Corp. (ATLN)
  • Cybin Inc. (CYBN)
  • LENSAR, Inc. (LNSR)
  • Lucid Diagnostics Inc. (LUCD)
  • MaxCyte, Inc. (MXCT)
  • Nkarta, Inc. (NKTX)

Recent insider activity

  • Moss Gregory S. — M-Exempt (17580 shares) on 2026-06-07
  • Moss Gregory S. — M-Exempt (17580 shares) on 2026-06-07
  • Roberts David B — M-Exempt (17580 shares) on 2026-06-07
  • Roberts David B — M-Exempt (17580 shares) on 2026-06-07
  • McDonnell Matthew — M-Exempt (60000 shares) on 2026-06-05

Open Anteris Technologies Global Corp. (AVR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.